Memantine hydrochloride slow-release pellet preparation and preparation method thereof

A technology of memantine hydrochloride and sustained-release pellets, which is applied in the direction of bulk delivery, active ingredients of amines, nervous system diseases, etc., can solve the problems of sudden release risks and safety hazards of sustained-release tablets, and achieve long-lasting and stable drug effects. Increased safety and good fluidity

Inactive Publication Date: 2013-12-04
HANGZHOU SHARPLY PHARM R&D INSTIT +2
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the sustained-release tablets can achieve the effect of stabilizing the blood drug concentration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Memantine hydrochloride slow-release pellet preparation and preparation method thereof
  • Memantine hydrochloride slow-release pellet preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0020] Example 1: Preparation of memantine hydrochloride sustained-release pellets

[0021] Prescription: Raw and auxiliary materials Weight (g)

[0022] Blank pill core 799

[0023] Memantine hydrochloride 56

[0024] Hypromellose 110

[0025] Talc 25

[0026] Polyethylene glycol 10

[0027] 95% ethanol is appropriate.

[0028] Preparation method: 1) Dissolve hypromellose with 95% ethanol, and dissolve memantine hydrochloride and polyethylene glycol with 95% ethanol and add them;

[0029] 2) The blank pellet core is placed in a coating machine, and after preheating, the drug sustained-release composite layer solution obtained in step 1) is sprayed on the blank pellet core, and the air inlet temperature is controlled at 40°C to prepare drug-containing pellets;

[0030] 3) Place the drug-containing pellets obtained in step 2) in a hot-air circulating oven at 60°C to 70°C for 2 hours to obtain sustained-release pellets; to obtain sustained-release pellets.

[0031] The sustained-release pellets...

Example Embodiment

[0032] Example 2:

[0033] prescription

[0034] Raw and auxiliary materials weight (g)

[0035] Blank pill core 789

[0036] Memantine hydrochloride 56

[0037] Stearic acid 120

[0038] Povidone 10

[0039] Talc 25

[0040] 95% ethanol is appropriate.

[0041] Preparation Process:

[0042] (1) Dissolve the stearic acid, memantine hydrochloride and povidone in the prescription with 95% ethanol and fully dissolve them, and stir well;

[0043] （2） The blank pellet core is placed in a coating machine, and after preheating, the drug sustained-release composite layer solution obtained in step (1) is sprayed on the blank pellet core, and the inlet air temperature is controlled at 40°C to prepare drug-containing pellets;

[0044] (3) Dry the drug-containing pellets obtained in step (2) in a hot air circulating oven at 60°C to 70°C for 2 hours to obtain sustained-release pellets;

[0045] The sustained-release pellets are filled into hollow capsules to obtain memantine hydrochloride sustained-release ...

Example Embodiment

[0046] Example three

[0047] prescription

[0048] Raw and auxiliary materials weight (g)

[0049] Blank pill core 799

[0050] Memantine hydrochloride 56

[0051] Acrylic resin (Utech NE30D) 110

[0052] Triethyl citrate 5

[0053] 95% ethanol

[0054] Preparation Process:

[0055] (1) Dissolve the stearic acid, memantine hydrochloride and povidone in the prescription with 95% ethanol and dissolve them thoroughly, and stir them evenly.

[0056] (2) Place the blank pellet core in the storage tank of the fluidized boiling coater, and pass hot air from the bottom to make it in a fluidized state. After the drug sustained-release composite solution of step (1) is sprayed through the bottom Spray in, spray the solution on the blank core and dry.

[0057] (3) The working parameters of the fluidized boiling coater are: the air supply temperature is set to 35~60℃; the fan frequency is set to 40~50hZ; the nozzle atomization pressure is 1.5~3.0bar.

[0058] The sustained-release pellets are filled int...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to a memantine hydrochloride slow-release pellet preparation and a preparation method thereof. The memantine hydrochloride slow-release pellet preparation comprises a blank pellet core as a nuclear parent and memantine hydrochloride medicine slow-release composite layer wrapped as an outer layer. The preparation is characterized in that the blank pellet core and the memantine hydrochloride medicine slow-release composite layer are in the weight ratio of 2-6:1; the memantine hydrochloride medicine slow-release composite layer contains 10-40% of memantine hydrochloride, 50-70% of a slow-release material and 0.1-20% of other accessories. The slow-release pellet prepared by the invention has high roundness and good fluidity, can obtain high yield during wrapping of medicine and the slow release material, and has good reappearance. The simple preparation technology of the slow-release pellet is not restrained by place or equipment and suitable for industrialized production.

Description

technical field [0001] The invention relates to a pharmaceutical preparation, in particular to a memantine hydrochloride sustained-release pellet preparation for treating Alzheimer's disease and a preparation method thereof. Background technique [0002] With the aging of the world's population and the improvement of people's living standards, the average life expectancy is also extended. In 2002, the elderly over the age of 60 accounted for 20% of the world's total population. By 2050, the number of elderly people It is expected to reach 21% of the world's total population. With the aging of the world's population, senile dementia has become the primary problem of human health, and the incidence rate is increasing year by year with the progress of population aging. At present, the number of sick people in the world has exceeded 18 million, and the number of sick people in my country is about 6 million, which is the country with the largest number of sick people in the worl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/16A61K31/13A61P25/28
Inventor 范敏华王美红刘华
Owner HANGZHOU SHARPLY PHARM R&D INSTIT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap